Active COVID-19 cases among Central Luzon cops hit 100 | Inquirer News

Active COVID-19 cases among Central Luzon cops hit 100

Active COVID-19 cases among Central Luzon cops hit 100

FILE PHOTO: Rookie policemen execute the hand salute during their formation at Camp Julian Olivas in the City of San Fernando, Pampanga province. On Monday, August 2), 2021, at least 1,284 police personnel in Central Luzon were inoculated with the single-shot Janssen vaccine. (Photo from the Police Regional Office 3 public information office).

OLONGAPO CITY — The number of active COVID-19 cases among the workforce of the Philippine National Police (PNP) in Central Luzon climbed to 100 on Thursday (Aug. 12), records showed.

According to the health service of the Police Regional Office 3 (PRO3), eight of its personnel have tested positive for COVID-19 on the same day.


The latest infections raised to 2,056 the total number of COVID-19 cases of PRO3 since last year.

But nine more virus-infected police in the region were cleared of the disease on Thursday, pushing to 1,951 PRO3’s number of recoveries. So far, PRO3 has a 94.8-percent recovery rate.


Its COVID-19 death toll was still at five with no additional fatalities in recent days.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: active cases, case bulletin, Central Luzon, COVID-19, PNP‎
For feedback, complaints, or inquiries, contact us.

News that matters

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.

© Copyright 1997-2022 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.